Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension

Published:2018-07-13 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Segura-Ibarra Victor,Wu Suhong,Hassan Nida,Moran-Guerrero Jose A.,Ferrari Mauro,Guha Ashrith,Karmouty-Quintana Harry,Blanco Elvin

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference142 articles.

1. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.;Acharya;Adv. Drug Deliv. Rev.,2011

2. Intratracheal administration of prostacyclin analogue-incorporated nanoparticles ameliorates the development of monocrotaline and sugen-hypoxia-induced pulmonary arterial hypertension.;Akagi;J. Cardiovasc. Pharmacol.,2016

3. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.;Akagi;Int. Heart J.,2015

4. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.;Anderson;Arthritis Res. Ther.,2010

5. Comparative safety and tolerability of endothelin receptor antagonists in pulmonary arterial hypertension.;Aversa;Drug Saf.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies;Journal of Controlled Release;2024-01

2. Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment;Small;2023-12-06

3. Design and fabrication of a microfluidic system with embedded circular channels for rotary cell culture;Biotechnology Journal;2023-04-26

4. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities;International Journal of Molecular Sciences;2023-03-08

5. Novel biocompatible polymer-modified liposome nanoparticles for biomedical applications;Polymer Bulletin;2023-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3